Association of PIK3CA somatic mutations with clinicopathological parameters in breast cancer
The enzyme phosphatidylinositide-3-kinase (PI3K) regulates cellular proliferation and apoptosis. Somatic mutations in the PIK3CA gene can accelerate these processes and significantly contribute to the development and progression of breast cancer. This study aimed to ascertain the PIK3CA gene mut...
Saved in:
Main Authors: | Gizem Teoman, Zeynep Turkmen Usta, Zeynep Sagnak Yilmaz, Sevdegul Aydin Mungan, Ismail Saygin |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2024-12-01
|
Series: | Polish Journal of Pathology |
Subjects: | |
Online Access: | https://www.termedia.pl/Association-of-PIK3CA-somatic-mutations-with-clinicopathological-parameters-in-breast-cancer,55,55290,1,1.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Promising Response with PI3K Inhibitor for a Patient with Heavily Pretreated PIK3CA Mutation Head-and-Neck Cancer
by: Ming-Jing Lee, et al.
Published: (2023-04-01) -
Predicting breast cancer prognosis using PR and PIK3CA biomarkers: a comparative analysis of diagnostic groups
by: Yuting Feng, et al.
Published: (2025-01-01) -
Effect of KRAS mutation status on clinicopathological characteristics and overall survival in patients with rectal cancer
by: Shengbin Zheng, et al.
Published: (2025-01-01) -
PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2− breast cancer
by: Eduardo Terán, et al.
Published: (2024-09-01) -
Somatic Mutaome Profile in Human Cancer Tissues
by: Nayoung Kim, et al.
Published: (2013-12-01)